3D Bioprinting Market to Grow at a Stable Rate During the Forecast Period

ALAMEDA, Calif. - Sept. 25, 2019 - PRLog -- The market is driven by factors, such as technological advancements and innovations, increasing compliance for drug discovery processes, and high demand for organ and tissue transplantation.

In terms of technology, the 3D bioprinting market (https://www.psmarketresearch.com/market-analysis/3d-bioprinting-market) has been segmented into syringe based 3D bioprinting, pneumatic extrusion based 3D bioprinting, inkjet based 3D bioprinting, laser based 3D bioprinting and others. The syringe based 3D bioprinting was the most commonly used bioprinting technology; whereas, pneumatic extrusion based 3D bioprinting is expected to witness the fastest growth during the foreast period.

Request for a sample: https://www.psmarketresearch.com/market-analysis/3d-bioprinting-market/report-sample

Asia-Pacific would be the fastest growing region in the 3D bioprinting market during 2016 - 2022. The region accounted for 20.0% share in the global market in 2015 and the share is expected to increase to 23.2% by 2022. The major reasons behind the fastest growth of the market in the region include increasing stem cell research, huge gap in demand supply for tissue and organ transplant, improving healthcare infrastructure, increasing prevalence of chronic diseases, technological advancements and increasing geriatric population.

Some of the major players operating in the 3D bioprinting market include Organovo Holdings, Inc., CELLINK, EnvisionTEC, BioBots, Cyfuse Biomedical K.K., Aspect Biosystems Ltd., 3D Bioprinting Solutions, Ourobotics, Advanced Solutions, Inc., GeSiM, Bio3D Technologies, 3Dynamic Systems Ltd., Nano3D Biosciences, Inc., Poietis, regenHU Ltd., and Aerotech Inc.

Read More.. (https://www.psmarketresearch.com/market-analysis/3d-biopr...)